Mitsubishi Chemical Holdings Corp, Japan’s largest chemical maker, said on Monday it will pay 491.8 billion yen ($4.51 billion) to make Mitsubishi Tanabe Pharma Corp (4508.T) a fully owned subsidiary.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
